534 related articles for article (PubMed ID: 15532789)
1. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
[TBL] [Abstract][Full Text] [Related]
2. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
3. The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer.
Kim MW; Kim WH; Wang HJ; Chung JB; Chun M
Hepatogastroenterology; 2001; 48(41):1298-301. PubMed ID: 11677950
[TBL] [Abstract][Full Text] [Related]
4. Impact of ductal resection margin status on long-term survival in patients undergoing resection for extrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Moroda T; Yokoyama N; Hatakeyama K
Cancer; 2005 Mar; 103(6):1210-6. PubMed ID: 15685618
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins.
Sakamoto Y; Kosuge T; Shimada K; Sano T; Ojima H; Yamamoto J; Yamasaki S; Takayama T; Makuuchi M
Surgery; 2005 Apr; 137(4):396-402. PubMed ID: 15800484
[TBL] [Abstract][Full Text] [Related]
6. [Significance of positive ductal margin and prognostic factors of surgical resection in middle and distal bile duct carcinoma].
Liang JW; Zhao P; Zhou ZX; Tian YT; Zhao DB; Wang CF
Zhonghua Wai Ke Za Zhi; 2009 May; 47(9):677-80. PubMed ID: 19615237
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing recurrence after surgical treatment for T2 gallbladder carcinoma.
Aramaki M; Matsumoto T; Shibata K; Himeno Y; Yada K; Hirano S; Sasaki A; Kawano K; Kitano S
Hepatogastroenterology; 2004; 51(60):1609-11. PubMed ID: 15532788
[TBL] [Abstract][Full Text] [Related]
8. Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients.
Hong SM; Kim MJ; Pi DY; Jo D; Cho HJ; Yu E; Ro JY
Cancer; 2005 Aug; 104(4):802-10. PubMed ID: 15959914
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
[TBL] [Abstract][Full Text] [Related]
11. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
12. Treatment strategy for patients with middle and lower third bile duct cancer.
Todoroki T; Kawamoto T; Koike N; Fukao K; Shoda J; Takahashi H
Br J Surg; 2001 Mar; 88(3):364-70. PubMed ID: 11260100
[TBL] [Abstract][Full Text] [Related]
13. Liver metastases after curative resection in patients with distal bile duct cancer.
Takao S; Shinchi H; Uchikura K; Kubo M; Aikou T
Br J Surg; 1999 Mar; 86(3):327-31. PubMed ID: 10201773
[TBL] [Abstract][Full Text] [Related]
14. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
[TBL] [Abstract][Full Text] [Related]
15. [Long-term results of 84 surgically treated patients with extrahepatic bile duct carcinoma].
Zheng SS; Qin YS; Liang TB; Huang DS; Zhang M; Wang WL; Shen Y; Wang JH
Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):554-6. PubMed ID: 16438856
[TBL] [Abstract][Full Text] [Related]
16. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
17. Results of primary surgery with T4 non-small cell lung cancer during a 25-year period in a single center: the benefit is worth the risk.
Yildizeli B; Dartevelle PG; Fadel E; Mussot S; Chapelier A
Ann Thorac Surg; 2008 Oct; 86(4):1065-75; discussion 1074-5. PubMed ID: 18805134
[TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
Lee PC; Port JL; Paul S; Stiles BM; Altorki NK
Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
[TBL] [Abstract][Full Text] [Related]
19. The survival outcome and prognostic factors for middle and distal bile duct cancer following surgical resection.
Choi SB; Park SW; Kim KS; Choi JS; Lee WJ
J Surg Oncol; 2009 May; 99(6):335-42. PubMed ID: 19226533
[TBL] [Abstract][Full Text] [Related]
20. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
